IBH — Indigenous Bloom Hemp Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2018 April 30th | 2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 14 | 11.9 | 1.76 | 0.666 | 2.37 |
Operating Profit | -14 | -11.9 | -1.76 | -0.666 | -2.37 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14 | -11.9 | -1.78 | -0.602 | -2.29 |
Net Income After Taxes | -14 | -11.9 | -1.78 | -0.602 | -2.29 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -13.9 | -11.9 | -1.78 | -0.602 | -2.29 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.9 | -11.9 | -1.78 | -0.602 | -2.29 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.1 | -1.97 | -0.57 | -0.121 | -0.009 |